About Saga Diagnostics
Saga Diagnostics is a company based in Lund (Sweden) founded in 2016 was acquired by Foundation Medicine in April 2026.. Saga Diagnostics has raised $17.87 million across 7 funding rounds from investors including Foundation Medicine, European Union and Segulah Medical Acceleration. Saga Diagnostics offers products and services including MRD Testing Platform and Liquid Biopsy Test. Saga Diagnostics operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter Lund, Sweden
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Saga Diagnostics Ab
-
Annual Revenue
$2.92 M (USD)434as on Dec 31, 2022
-
Net Profit
$-2.63 M (USD)0as on Dec 31, 2022
-
EBITDA
$-2.63 M (USD)0as on Dec 31, 2022
-
Total Equity Funding
$17.87 M (USD)
in 7 rounds
-
Latest Funding Round
$12.47 M (USD), Series A
Jun 29, 2021
-
Investors
Foundation Medicine
& 11 more
-
Employee Count
Employee Count
-
Acquired by
Foundation Medicine
(Apr 16, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Saga Diagnostics
Saga Diagnostics offers a comprehensive portfolio of products and services, including MRD Testing Platform and Liquid Biopsy Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects residual cancer cells via liquid biopsy for personalized oncology care.
Monitors tumor variants in blood to assess treatment response and recurrence.
Unlock access to complete
Funding Insights of Saga Diagnostics
Saga Diagnostics has successfully raised a total of $17.87M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $12.47 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $12.5M
-
First Round
First Round
(04 Apr 2016)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series A - Saga Diagnostics | Valuation | Segulah Medical Acceleration | |
| Feb, 2021 | Amount | Grant - Saga Diagnostics | Valuation |
investors |
|
| Jun, 2019 | Amount | Series A - Saga Diagnostics | Valuation | Hadean Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Saga Diagnostics
Saga Diagnostics has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Foundation Medicine, European Union and Segulah Medical Acceleration. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment support is provided for life science and high tech.
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Saga Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Saga Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Saga Diagnostics Comparisons
Competitors of Saga Diagnostics
Saga Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Saga Diagnostics
Frequently Asked Questions about Saga Diagnostics
When was Saga Diagnostics founded?
Saga Diagnostics was founded in 2016.
Where is Saga Diagnostics located?
Saga Diagnostics is headquartered in Lund, Sweden.
Is Saga Diagnostics a funded company?
Saga Diagnostics is a funded company, having raised a total of $17.87M across 7 funding rounds to date. The company's 1st funding round was a Series A of $4.2M, raised on Apr 04, 2016.
What is the annual revenue of Saga Diagnostics?
Annual revenue of Saga Diagnostics is $2.92M as on Dec 31, 2022.
What does Saga Diagnostics do?
Saga Diagnostics was founded in 2016 in Lund, Sweden, and operates in the biotechnology sector focused on oncology diagnostics. Next-generation sequencing and proprietary algorithms are utilized to identify cell-free tumor DNA in blood samples. Products such as SAGAsafe, SAGAsign, and SAGAseq are developed to detect mutations and assess therapeutic responses. Services for analyzing gene and chromosomal mutations are also provided to support clinical research and patient monitoring.
Who are the top competitors of Saga Diagnostics?
Saga Diagnostics's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
What products or services does Saga Diagnostics offer?
Saga Diagnostics offers MRD Testing Platform and Liquid Biopsy Test.
Who are Saga Diagnostics's investors?
Saga Diagnostics has 12 investors. Key investors include Foundation Medicine, European Union, Segulah Medical Acceleration, Hadean Ventures, and Gunnar Nilssons Cancerstiftelse.